Given the known role of IL-1 in sepsis, the use of mAbs against IL-1 may represent a new promising approach to suppress neuroinflammation in patients with sepsis and prevent long-term cognitive impairments, but further studies are required. Here, IL1B is linked to Cognitive impairment.